| Financial Year |
March 31 2023 |
| Monetary Funds |
1,790,291,996.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
109,507,714.40 |
| Accounts Receivable |
1,067,823,156.47 |
| Advances to Suppliers |
140,722,413.25 |
| Other Receivables |
24,383,807.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
689,142,354.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,452,441.83 |
| Total Current Assets |
4,284,473,126.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,746,211.94 |
| Long-term Equity Investment |
432,133,377.85 |
| Investment Properties |
-- |
| Fixed Assetes |
1,401,345,264.61 |
| Under-construction Projects |
836,223,907.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
284,297,087.99 |
| R&D expenses |
5,793,418.85 |
| Goodwill |
220,475,673.91 |
| Long-Term Deferred and Prepaid Expenses |
22,574,950.66 |
| Deferred Income Tax Assets |
83,960,999.42 |
| Other Non-Current Assets |
73,348,919.75 |
| Sub-Total of Non-Current Assets |
3,364,346,017.28 |
| Total Assets |
7,648,819,143.47 |
| Short-Term Loans |
1,571,008,219.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
816,827,047.40 |
| Accounts Payable |
713,423,686.95 |
| Accounts Received In Advance |
2,325,175.78 |
| Employee Compensation Payable |
23,015,776.35 |
| Taxes Payable |
14,026,310.44 |
| Interest Payable |
1,760,415.85 |
| Dividend Payable |
737,893.28 |
| Other payables |
18,926,487.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
147,440,821.57 |
| Other Current Liabilities |
2,825,959.28 |
| Sub-Total of Current Liabilities |
3,336,853,280.98 |
| Long-term Loans |
941,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,803,444.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,065,487.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,013,727,421.84 |
| Total Liabilities |
4,350,580,702.82 |
| Paid-In Capital(Or Share Stock) |
1,072,073,187.00 |
| Capital Surplus |
1,529,777,938.81 |
| Surplus Reserve |
59,820,585.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-166,075,549.50 |
| Minority Stockholder's Interest |
804,283,232.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,493,955,208.31 |
| Owner's Equity（Stockholder's Equity） |
3,298,238,440.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,648,819,143.47 |
